AKEBIA THERAPEUTICS, INC. Increase (Decrease) in Inventories
AKEBIA THERAPEUTICS, INC. (AKBA) reported Increase (Decrease) in Inventories of $3.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $655.00K, a 91.44% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $2.54M, a 48.72% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $17.42M, a 105.01% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$6.90M, a 1365.87% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2025 was $23.13M, a 18.58% decline from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $28.40M, a 1017.27% increase from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was $2.54M.
- AKEBIA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was -$19.09M, a 176.51% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.19M 10-Q · filed 2026-08-05 | $20.61M derived: sum of 3 quarters · filed 2026-08-05 | $13.71M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $2.54M 10-Q · filed 2026-05-07 | $19.96M derived: sum of 2 quarters · filed 2026-05-07 | $13.06M derived: sum of 3 quarters · filed 2026-05-07 | $20.71M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $17.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.52M derived: sum of 2 quarters · filed 2026-02-26 | $18.17M derived: sum of 3 quarters · filed 2026-08-05 | $23.13M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $754.00K derived: sum of 2 quarters · filed 2026-08-05 | $5.71M 10-Q · filed 2025-11-10 | $14.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $7.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $12.61M 10-Q · filed 2026-08-05 | $21.10M derived: sum of 3 quarters · filed 2026-08-05 | $21.65M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $4.95M 10-Q · filed 2026-05-07 | $13.45M derived: sum of 2 quarters · filed 2026-05-07 | $13.99M derived: sum of 3 quarters · filed 2026-05-07 | $28.92M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.04M derived: sum of 2 quarters · filed 2026-02-26 | $23.97M derived: sum of 3 quarters · filed 2026-02-26 | $28.40M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $15.47M derived: sum of 2 quarters · filed 2025-11-10 | $19.91M 10-Q · filed 2025-11-10 | $31.68M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $14.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $19.36M 10-Q · filed 2025-08-07 | $31.14M derived: sum of 3 quarters · filed 2026-02-26 | $32.73M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $4.43M 10-Q · filed 2025-05-08 | $16.21M derived: sum of 2 quarters · filed 2026-02-26 | $17.80M derived: sum of 3 quarters · filed 2026-02-26 | $14.32M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.37M derived: sum of 2 quarters · filed 2026-02-26 | $9.89M derived: sum of 3 quarters · filed 2026-02-26 | $2.54M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.89M derived: sum of 2 quarters · filed 2024-11-07 | -$9.24M 10-Q · filed 2024-11-07 | -$33.69M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$10.83M 10-Q · filed 2024-08-08 | -$35.28M derived: sum of 3 quarters · filed 2024-08-08 | -$34.28M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$7.35M 10-Q · filed 2024-05-09 | -$31.80M derived: sum of 2 quarters · filed 2024-05-09 | -$30.80M derived: sum of 3 quarters · filed 2024-05-09 | -$34.92M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$24.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$23.45M derived: sum of 2 quarters · filed 2024-03-14 | -$27.58M derived: sum of 3 quarters · filed 2024-03-14 | -$19.09M 10-K · filed 2024-03-14 | -$19.79M 10-K · filed 2023-03-10 | |||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-K/A 6 month · filed 2023-11-08 | -$3.13M derived: sum of 2 quarters · filed 2023-11-08 | $5.37M 10-Q · filed 2023-11-08 | -$1.41M 10-Q · filed 2022-11-03 | -$4.97M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$4.13M derived: 10-K/A 6 month − 10-K/A 3 month · filed 2023-08-28 | $4.36M 10-K/A · filed 2023-08-28 | -$1.16M 10-Q · filed 2022-08-04 | -$5.97M derived: sum of 3 quarters · filed 2023-08-28 | -$6.40M derived: sum of 4 quarters · filed 2023-08-28 | |||
| 2022-03-31 | $8.49M 10-K/A · filed 2023-08-28 | $5.25M 10-Q · filed 2022-05-09 | -$1.84M derived: sum of 2 quarters · filed 2023-08-28 | -$2.27M derived: sum of 3 quarters · filed 2023-08-28 | $14.24M derived: sum of 4 quarters · filed 2023-08-28 | |||
| 2021-12-31 | -$10.34M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$10.76M derived: sum of 2 quarters · filed 2023-08-28 | $5.75M derived: sum of 3 quarters · filed 2023-08-28 | $24.95M 10-K/A · filed 2023-08-28 | $25.85M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $16.09M derived: sum of 2 quarters · filed 2022-11-03 | $35.28M 10-Q · filed 2022-11-03 | $35.53M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2021-06-30 | $16.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $35.71M 10-Q · filed 2022-08-04 | $35.96M derived: sum of 3 quarters · filed 2023-08-28 | $23.87M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2021-03-31 | $19.19M 10-Q · filed 2022-05-09 | $19.45M derived: sum of 2 quarters · filed 2023-08-28 | $7.35M derived: sum of 3 quarters · filed 2023-08-28 | $4.87M derived: sum of 4 quarters · filed 2023-08-28 | ||||
| 2020-12-31 | $252.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-28 | -$11.84M derived: sum of 2 quarters · filed 2023-08-28 | -$14.33M derived: sum of 3 quarters · filed 2023-08-28 | -$6.16M 10-K/A · filed 2023-08-28 | ||||
| 2020-09-30 | -$12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$14.58M derived: sum of 2 quarters · filed 2021-11-04 | -$6.42M 10-Q · filed 2021-11-04 | -$5.84M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $5.68M 10-Q · filed 2021-08-05 | $6.26M derived: sum of 3 quarters · filed 2022-03-01 | $17.63M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $8.16M 10-Q · filed 2021-05-10 | $8.74M derived: sum of 2 quarters · filed 2022-03-01 | $20.12M derived: sum of 3 quarters · filed 2022-03-01 | $21.24M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $11.95M derived: sum of 2 quarters · filed 2022-03-01 | $13.08M derived: sum of 3 quarters · filed 2022-03-01 | $29.14M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $11.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $12.50M derived: sum of 2 quarters · filed 2020-11-05 | $28.57M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $17.19M 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | $16.06M 10-Q · filed 2020-05-05 | |||||||
| 2018-12-31 | -$26.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |